FDA approval for multiple myeloma treatment

On February 26, 2021 the Food and Drug Administration (FDA) granted accelerated approval to melphalan flufenamide for relapsed or refractory multiple myeloma.
Learn more about myeloma and multiple myeloma treatments on our website: canceredinstitute.org/myeloma-treatments

#Empowermentagainstcancer™
#CERIinforms
#CERICares
#CancerSimplified

Learn more about myeloma and multiple myeloma on our website: canceredinstitute.org/myeloma

If you need help for your cancer treatment and care, apply to our CERI Personalized Patient Program™: canceredinstitute.org/patient-program

#fdaapproval #FDA #multiplemyeloma #myeloma #multiplemyelomatreatment #multiplemyelomaawareness #myelomaawareness #MyelomaAwarenessMonth